Mepolizumab in chronic rhinosinusitis with nasal polyposis.

Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a heterogeneous upper airway disease that is prevalent globally. Recent research into the molecular basis of the disease has led to the development of biologics as a new therapeutic option for severe and recalcitrant forms of CRSwNP. Mepolizumab is a monoclonal antibody targeting IL-5, one of the signature cytokines of the type 2 immune response and which plays an important role in the pathogenesis of CRSwNP. Here we present the latest evidence behind mepolizumab, examining disease pathophysiology and pharmacology, as well as data from clinical trials, real-life studies and meta-analyses. As we welcome this promising step forward into precision medicine, we discuss practical issues and future perspectives on mepolizumab and biologics for CRSwNP.

Mepolizumab is a new injectable drug developed to control difficult-to-treat cases of chronic rhinosinusitis with nasal polyposis (CRSwNP), an inflammatory disease of the nose that affects many people worldwide. It works by blocking the action of IL-5, an important protein in the body that regulates inflammation. One of the main effects of this protein is promoting the activity of eosinophils, a type of white blood cell. Eosinophils contribute to tissue damage when activated inappropriately. A recent large-scale study (SYNAPSE) on patients using this drug has been completed, reporting favorable results. In this article, we discuss the science behind the disease, the drug and data from patient studies. We conclude by discussing several future challenges and opportunities in the management of CRSwNP.

Next-Generation Allergic Rhinitis Care in Singapore: 2019 ARIA Care Pathways.

Allergic rhinitis (AR) is prevalent in Singapore, with a significant disease burden. Afflicting up to 13% of the population, AR impairs quality of life, leads to reduced work productivity and is an independent risk factor for asthma. In the last 2 decades, local studies have identified patient and physician behaviours leading to suboptimal control of the disease. Yet, there is an overall lack of attention to address this important health issue. Allergic Rhinitis and its Impact on Asthma (ARIA) is a European organisation aimed at implementing evidence-based management for AR worldwide. Recent focus in Europe has been directed towards empowering patients for self-management, exploring the complementary role of mobile health, and establishing healthcare system-based integrated care pathways. Consolidation of these ongoing efforts has led to the release of the 2019 ARIA care pathways. This review summarises the ARIA update with particular emphasis on the current status of adult AR in Singapore. In addition, we identify unmet needs and future opportunities for research and clinical care of AR in the local context.

Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.

OBJECTIVES: To compare the clinical outcomes of oligometastatic versus widely metastatic NPC patients. MATERIALS AND METHODS: Retrospective review of 157 patients with metastatic NPC at a tertiary hospital was performed. Multivariate analysis was carried out to compare the overall and progression-free survival (OS and PFS) of these two cohorts of NPC patients. The number of organ involvement and discrete metastatic lesions associated with improved OS and PFS were ascertained. RESULTS: Patients with oligometastatic NPC (single organ, less than six discrete metastatic lesions) had a better median OS than patients with widespread metastasis (24.8 versus 12.8 months, P < .001). Similarly, the median PFS of oligometastatic NPC was better than that of polymetastatic NPC (11.7 versus 7.3 months, P < .001). CONCLUSION: Single organ disease with less than six discrete lesions is a good indicator of limited metastatic load in NPC, and is associated with improved survival.

The efficacy of sublingual immunotherapy for allergic diseases in Asia.

Sublingual immunotherapy (SLIT) has been proven to be safe and effective from an abundance of Western literature, but data from Asia is less complete. This review aims to examine the basic science, safety and efficacy of SLIT in Asian patients, and to determine future research needs in Asia. We performed a literature search on PUBMED, Scopus, and Cochrane Library database for articles on SLIT originating from Asian countries through Nov 2017. There were 18 randomized, double-blind, placebo-controlled trials, of which 9 involved solely paediatric subjects. Overall, sublingual immunotherapy is safe and is efficacious in Asian populations in allergic rhinitis (AR) and asthma. House dust-mite SLIT is effective in both mono- and polysensitized AR patients. Efficacy of SLIT is comparable to subcutaneous immunotherapy. Data on long term efficacy is lacking. A disproportionate majority of research originates from China and Japan, reflecting an asymmetry of access to SLIT within Asia. Significant disparities exist in the development of the allergy speciality, prescription patterns of SLIT, and pharmacological potencies of different SLIT products within and between Asian nations. We conclude that current available evidence suggests SLIT is efficacious in Asians but data quality of evidence is hampered by non-placebo controlled studies with methodological limitations. More data is needed in South and Southeast Asian populations. Future efforts may be directed towards improving access to SLIT in developing countries, standardization of SLIT dosage, and evaluating long term clinical outcomes.

Angioembolisation of a Bleeding Meckel's Diverticulum.

We describe the diagnosis of an adult who presented with hematochezia. This was investigated and found to be from a bleeding Meckel's diverticulum. As this condition is rare in adults, there is no consensus regarding the optimal mode of management. We propose the use of angioembolisation in the diagnostic and therapeutic management of this condition. Our case showed that this strategy is indeed feasible and can achieve good short-term control, allowing for definitive surgery in an elective setting.

An Innovative 3-dimensional Model of the Epitympanum for Teaching of Middle Ear Anatomy.

OBJECTIVE: To facilitate teaching of the anatomy of the epitympanum, we developed and evaluated the effectiveness of an interactive 3-dimensional (3D) computer model that can be viewed from all angles. STUDY DESIGN: Questionnaire-based prospective randomized controlled trial. SETTING: Undergraduate medical education program. SUBJECTS AND METHODS: The model was created using Google Sketchup, a 3D modeling software. We recruited 72 graduating medical students and randomized them into 2 groups. One group was given the 3D model and reading materials on the epitympanic anatomy (3D group), while the other group relied on reading material and pictures (2-dimensional [2D] group). A questionnaire and anatomy quiz assessed the utility of the 3D model in learning the anatomy of the epitympanum. RESULTS: The mean age of the participants was 22 years. There were no statistically significant differences in demographics and previous experience with 3D models. The 3D group was significantly more confident in its ability to identify structures of the epitympanum on pictures and computed tomography scans when compared to the 2D group. Most participants were in favor of the model as a useful learning tool and preferred to use it with an instructor. In the anatomy quiz, the 3D group fared significantly better, achieving a mean score of 65.1% compared to 32.4% in the 2D group (P < .001). CONCLUSION: The 3D teaching model of the epitympanum is efficacious in short-term recall. By allowing the learner to visualize relations of the epitympanum from all directions, the model aids in appreciation of anatomy and identifications of structures of this region.

To LIFT or to flap? Which surgery to perform following seton insertion for high anal fistula?

BACKGROUND: The ideal surgery following seton insertion for high anal fistulas remains debatable. OBJECTIVE: This study aimed to compare the success between the endorectal advancement flap and the ligation of intersphincteric fistula tract techniques as the definitive procedure following seton placement. DESIGN: This study is a retrospective review. SETTINGS: This study was conducted at the Division of Colorectal Surgery, University Surgical Cluster, National University Health System, Singapore, between April 2006 and July 2011. PATIENTS AND INTERVENTIONS: After seton placement for high anal fistulas, 31 and 24 patients underwent the endorectal advancement flap and the ligation of intersphincteric fistula tract procedures. MAIN OUTCOME MEASURES: Failure was defined as the nonhealing of the surgical wounds or persistent discharge at the external opening. RESULTS: We identified 31 patients with a median age of 49 (range, 19-74) years in the endorectal advancement flap group. The median interval from the seton procedure to the flap procedure was 13 (range, 4-284) weeks. Over a median follow up of 6 (range, 2-26) months, 29 (93.5%) patients had successful outcomes. There were 24 patients, median age 41 (range, 16-75) years, in the ligation of intersphincteric fistula tract group. The median interval from the seton placement to the definitive surgery was 14 (range, 8-74) weeks. Over a median follow-up of 13 (range, 4-67) months, 15 (62.5%) patients had successful outcomes. Hence when performed as the initial definitive procedure after a seton, the endorectal advancement flap technique had a significantly higher success rate in comparison with the ligation of intersphincteric fistula tract approach (93.5% vs 62.5%) (p = 0.006). CONCLUSION: In patients who have had seton placement for high anal fistulas, the endorectal advancement flap technique is associated with better short-term outcomes in comparison with the ligation of intersphincteric fistula tract technique.